Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/44469
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDelea, T.en
dc.contributor.authorKarnon, J.en
dc.contributor.authorGoss, P.en
dc.date.issued2007en
dc.identifier.citationAnnals of Oncology, 2007; 18(1):197-198en
dc.identifier.issn0923-7534en
dc.identifier.issn1569-8041en
dc.identifier.urihttp://hdl.handle.net/2440/44469-
dc.description.statementofresponsibilityTE Delea, J Karnon and PE Gossen
dc.language.isoenen
dc.publisherOxford Univ Pressen
dc.rightsCopyright © 2006 European Society for Medical Oncologyen
dc.subjectHumans; Breast Neoplasms; Aromatase Inhibitors; Postmenopause; Cost-Benefit Analysis; Drug Costs; Femaleen
dc.titleConclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureen
dc.typeJournal articleen
dc.identifier.rmid0020076129en
dc.identifier.doi10.1093/annonc/mdl171en
dc.identifier.pubid45167-
pubs.library.collectionPublic Health publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidKarnon, J. [0000-0003-3220-2099]en
Appears in Collections:Public Health publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.